Study has implied that MM cells secrete CST6 to block RANKL-induced osteoclast maturation by inhibiting cathepsin-mediated cleavage of NF-κB/p100 and TRAF3, thereby alleviating bone loss in MM patients (130). Here, NFKB1 is linked to Miyoshi myopathy.